Motley Fool analysis indicates that medical device giant Medtronic (MDT) achieved an 8.4% revenue growth to $36.4 billion in fiscal year 2026 (ending this April), marking its highest growth rate in a decade. The company projects organic revenue growth of 7.25%-7.75% for fiscal year 2027 and has raised its dividend for 49 consecutive years, with a current dividend yield of 3.1%. Analysts anticipate a compound annual growth rate (CAGR) of 14% for its EPS from fiscal year 2026 to 2029. Medtronic's current stock price is $92, with a price-to-earnings (P/E) ratio of only 18 times next year's estimated earnings, which is below the S&P 500 index and industry average, making its valuation attractive.